Skip to main content

Details for 'ALS-PCS v5.3 - Hypoglycemia Medical Directive'

Name ALS-PCS v5.3 - Hypoglycemia Medical Directive
Description In response to a critical shortage of intramuscular (IM) glucagon, intranasal (IN) glucagon has been approved and added to the Hypoglycemia Medical Directive. The MOH released this on February 9, 2024, in the Advanced Life Support Patient Care Standards v5.3.
License
File name ALS PCS v5.3 Memo IN Glucagon 15.2.24.pdf
Version 5.3
Size 553.65 KB
File type pdf (Mime type application/pdf)
Owner Niall Sheehan
Date added 20/02/2024 06:25:11
Hits 334
Last modified on 21/02/2024 06:50:15
MD5 checksum 13dc301cd054fe778c97d3bb777bfa4d